Published in Biochem Pharmacol on February 01, 1973
Regulation of cAMP by phosphodiesterases in erythrocytes. Pharmacol Rep (2010) 0.87
The stimulation of adenyl cyclase of rat erythrocyte ghosts. Mol Pharmacol (1970) 1.43
Investigation of the mechanism of action of the lipolytic agent 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956). J Pharmacol Exp Ther (1970) 0.89
The effect of alpha, beta, and dopamine receptor-blocking agents on the stimulation of rat erythrocyte adenyl cyclase by dihydroxyphenethylamines and their beta-hydroxylated derivatives. Mol Pharmacol (1971) 0.78
Effect of tetrahydroisoquinoline derivatives on the adenylate cyclases of the caudate nucleus (dopamine-type) and erythrocyte (beta-type) of the rat. Res Commun Chem Pathol Pharmacol (1974) 0.78
The effect of dihydroxy-2-aminotetraline (DATs) on dopamine and beta type adenylate cyclases. Res Commun Chem Pathol Pharmacol (1978) 0.75
A structure-activity analysis of the preferred conformation of the benzyl substituent of tetrahydropapaveroline at the beta receptor. Res Commun Chem Pathol Pharmacol (1977) 0.75
The dopamine-sensitive adenylate cyclase of the rat caudate nucleus. II. A comparison with the isoproterenol-sensitive (beta) adenylate cyclase of the rat erythrocyte for inhibition or stimulation by tetrahydroisoquinolines. Mol Pharmacol (1976) 0.75
Retained inhibition of the beta receptor by propranolol after preincubation and washout. Res Commun Chem Pathol Pharmacol (1978) 0.75